Idorsia Ltd (IDIA.SW)

CHF 1.3

(2.45%)

Revenue Summary of Idorsia Ltd

Idorsia Ltd's latest annual revenue in 2023 was 152.38 Million CHF , up 56.93% from previous year.
Idorsia Ltd's latest quarterly revenue in 2024 Q3 was 26 Million CHF , up 38.86% from previous quarter.
Idorsia Ltd reported a annual revenue of 97.1 Million CHF in annual revenue 2022, up 174.7% from previous year.
Idorsia Ltd reported a annual revenue of 35.34 Million CHF in annual revenue 2021, down -50.74% from previous year.
Idorsia Ltd reported a quarterly revenue of 10.05 Million CHF for 2024 Q1, down -53.25% from previous quarter.
Idorsia Ltd reported a quarterly revenue of 16.34 Million CHF for 2024 Q2, up 62.55% from previous quarter.

Annual Revenue Chart of Idorsia Ltd (2023 - 2016)

Historical Annual Revenue of Idorsia Ltd (2023 - 2016)

Year	Revenue	Revenue Growth
2023	152.38 Million CHF	56.93%
2022	97.1 Million CHF	174.7%
2021	35.34 Million CHF	-50.74%
2020	71.75 Million CHF	201.26%
2019	23.81 Million CHF	-60.71%
2018	60.61 Million CHF	-61.65%
2017	158.08 Million CHF	0.0%
2016	- CHF	0.0%

Year	Revenue	Revenue Growth
2024 Q3	26 Million CHF	38.86%
2024 Q1	10.05 Million CHF	-53.25%
2024 Q2	16.34 Million CHF	62.55%
2023 Q3	79.91 Million CHF	167.01%
2023 FY	152.38 Million CHF	56.93%
2023 Q1	21.02 Million CHF	-61.14%
2023 Q2	29.93 Million CHF	42.35%
2023 Q4	21.51 Million CHF	-73.08%
2022 Q3	20.73 Million CHF	21.44%
2022 FY	97.1 Million CHF	174.7%
2022 Q4	54.1 Million CHF	160.87%
2022 Q2	17.07 Million CHF	229.5%
2022 Q1	5.18 Million CHF	4.12%
2021 FY	35.34 Million CHF	-50.74%
2021 Q4	4.97 Million CHF	-69.9%
2021 Q3	16.54 Million CHF	137.47%
2021 Q2	6.96 Million CHF	1.44%
2021 Q1	6.86 Million CHF	17.91%
2020 FY	71.75 Million CHF	201.26%
2020 Q3	7.77 Million CHF	-85.37%
2020 Q1	5.02 Million CHF	21.18%
2020 Q2	53.13 Million CHF	957.91%
2020 Q4	5.82 Million CHF	-25.09%
2019 Q2	6.55 Million CHF	0.0%
2019 Q1	6.55 Million CHF	-83.98%
2019 FY	23.81 Million CHF	-60.71%
2019 Q4	4.14 Million CHF	-36.79%
2019 Q3	6.55 Million CHF	0.0%
2018 Q3	6.55 Million CHF	0.0%
2018 Q1	6.55 Million CHF	-96.54%
2018 FY	60.61 Million CHF	-61.65%
2018 Q4	40.94 Million CHF	524.34%
2018 Q2	6.55 Million CHF	0.0%
2017 FY	158.08 Million CHF	0.0%
2017 Q1	- CHF	0.0%
2017 Q2	165.29 Million CHF	0.0%
2017 Q4	189.7 Million CHF	0.0%
2017 Q3	- CHF	-100.0%
2016 FY	- CHF	0.0%

Peer Revenue Comparison of Idorsia Ltd

Name	Revenue	Revenue Difference
Addex Therapeutics Ltd	1.61 Million CHF	-9322.9%
BB Biotech AG	-199.56 Million CHF	176.358%
Basilea Pharmaceutica AG	157.63 Million CHF	3.329%
Evolva Holding SA	9.43 Million CHF	-1514.635%
Kuros Biosciences AG	33.56 Million CHF	-354.016%
Molecular Partners AG	7.03 Million CHF	-2065.189%
Relief Therapeutics Holding AG	6.03 Million CHF	-2425.874%
Santhera Pharmaceuticals Holding AG	103.41 Million CHF	-47.355%